Detalhe da pesquisa
1.
Safety, tolerability, pharmacokinetic, pharmacodynamic and immunogenicity profiles of Exendin-4-IgG4-Fc in healthy subjects: A phase 1, single-centre, randomized, double-blind, dose escalation study.
Diabetes Obes Metab
; 26(4): 1395-1406, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38287130
2.
Targeting glycolysis in non-small cell lung cancer: Promises and challenges.
Front Pharmacol
; 13: 1037341, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36532721